As ovarian cancer is still the most lethal gynecological cancer and is mainly diagnosed in its advanced stages, timely risk-reducing bilateral salpingoophorectomy (RRBSO) is recommended for BRCA1/2 mutation carriers. This evidence concerns the gene BRCA1 and ovarian cancer.